Sen. Sanders Calls on Trump to Rescind Pharma Giveaway of Potential Coronavirus Treatment
March 25, 2020
March 25, 2020
WASHINGTON, March 25 -- Sen. Bernie Sanders, I-Vermont, issued the following statement regarding the decision by the Trump administration's Food and Drug Administration to grant Gilead Sciences a seven-year monopoly for antiviral medication remdesivir for potential treatment of the coronavirus:
"It is truly outrageous that after taxpayers put tens of millions of dollars into developing remdesivir, Trump's FDA is exploiting a law reserved for rare diseases to privatize a drug t . . .
"It is truly outrageous that after taxpayers put tens of millions of dollars into developing remdesivir, Trump's FDA is exploiting a law reserved for rare diseases to privatize a drug t . . .